Vystar Corporation announced that on December 17, 2020, Mr. Keith Osborn announced his retirement as a director, which was made effective January 25, 2021. Mr. Osborn has served as a director since 2016. On January 25, 2021, Byron L. Novosad, DDS, was appointed by unanimous consent of the Board as a member of the Board of Directors to fill the vacancy. Dr. Novosad brings experience to the Board in the medical and health care field, and served previously as a consultant to UV Flu Technologies from 2011 to 2015 and a consultant to Vystar Corp. 2013 to 2015. Prior to engaging MGO, the company did not consult with MGO regarding the application of accounting principles to a specific completed or proposed transaction or regarding the type of audit opinions that might be rendered by MGO on the company's financial statements, and MGO did not provide any written or oral advice that was an important factor considered by the company in reaching a decision as to any such accounting, auditing or financial reporting issue.